LivaNova PLC (LIVN)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Vladimir A. Makatsaria
|
CEO & Director | 2.37M | -- | 1973 |
|
Mr. Alex Shvartsburg C.M.A.
|
Chief Financial Officer | 1.12M | -- | 1970 |
|
Ms. Natalia Sergeyevna Kozmina
|
Chief Human Resources Officer | 1.09M | -- | 1971 |
|
Mr. Ahmet Tezel Ph.D.
|
Chief Innovation Officer | 1.07M | -- | 1975 |
|
Ms. Lindsey Little
|
VP & Chief Accounting Officer | -- | -- | -- |
|
Briana Gotlin
|
Vice President of Investor Relations | -- | -- | -- |
|
Ms. Anne M. Liddy
|
Chief Legal Officer | -- | -- | 1976 |
|
Deanna Wilke
|
Vice President of Corporate Communications | -- | -- | -- |
|
Mr. Philip Kowalczyk
|
Chief Strategy & Corporate Development Officer | -- | -- | -- |
|
Mr. Paul R. Buckman
|
President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | -- | -- | 1956 |
LivaNova PLC
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 3,300
Description
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Corporate Governance
Upcoming Events
November 4, 2026 at 12:30 PM UTC
LivaNova PLC Earnings Date
Recent Events
May 29, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
